---
title: Targeting cellular cathepsins inhibits hepatitis E virus entry
date: '2024-05-10'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38728662/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240511181529&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: In summary, our study highlights the pivotal role of lysosomal
  cathepsins, especially CTSL, in the HEV entry process. The profound anti-HEV efficacy
  of the pan-cathepsin inhibitor, K11777, especially with its notable safety profile
  in primary cells, further underscores its potential as a therapeutic ...'
disable_comments: true
---
CONCLUSIONS: In summary, our study highlights the pivotal role of lysosomal cathepsins, especially CTSL, in the HEV entry process. The profound anti-HEV efficacy of the pan-cathepsin inhibitor, K11777, especially with its notable safety profile in primary cells, further underscores its potential as a therapeutic ...